Desk›Healthcare› Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital And Institute Ltd
BSE 532998 · NSE LOTUSEYE · ISIN INE947I01017 · Group B · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹112.80
+0.09%
BSE close, 28 August 2026
₹234.58 cr
2.1 cr shares · Micro cap
₹135.29 cr
as published
1,611.4× · 3.90×
EPS ₹0.07 · BV ₹28.92
53.71 / 0.08
₹ cr, as filed
11
3 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -26.3% |
|---|---|
| Against 52-week low | +15.6% |
| Day change | +0.09% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹0.07 |
|---|---|
| Price / earnings | 1,611.43× |
| Price / book | 3.90× |
| Book value — derived, price ÷ P/B | ₹28.92 |
| Return on equity | 0.25% |
| Operating margin | 18.48% |
| Net margin | 3.60% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 0.24%
- ROE as published
- 0.25%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 17.06 | 0.61 | 0.30 | 18.48% | 3.60% |
| Mar-26 · Q | 13.61 | -0.32 | -0.15 | 7.00% | -2.35% |
| FY25-26 | 53.71 | 0.08 | 0.04 | 8.48% | 0.15% |
Quarter on quarter
- Revenue, quarter on quarter
- +25.3%
- Net profit, quarter on quarter
- +290.6%
- Operating margin, quarter on quarter
- +1,148 bps
Disclosure profile 11 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 3 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 8 |
| Total | 11 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
11 filings · 3 selected · busiest 2026-09-01
Filing rhythm · the twelve most recent
2026-08-102026-10-08
SelectedProcedural
Filings
11 in the window · 2 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results and Scrutinizer Report for the 29th Annual General Meeting
AGM/EGM / AGM View filing →
-
23 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 29th Annual General Meeting
AGM/EGM / AGM View filing →
-
1 September 2026 ·
Newspaper Publication
Newspaper Advertisements published for 29th Annual General Meeting of the Company and Annual Report for the financial year 2025-26.
Company Update / Newspaper Publication View filing →
-
1 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the financial year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
1 September 2026 ·
29Th Annual General Meeting Of The Company - September 23, 2026
AGM Notice
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Press Release / Media Release
Launches "Lotus Optique", a new optical store.
Company Update / Press Release / Media Release View filing →
-
11 August 2026 ·
Newspaper Publication
Newspaper Advertisements published for Standalone Unaudited Financial Results for the quarter ended June 30, 2026
Company Update / Newspaper Publication View filing →
-
10 August 2026 ·
Results - Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026
Standalone Unaudited Financial Results for the quarter ended June 30, 2026.
Result / Financial Results View filing →
-
10 August 2026 ·
Board Meeting Outcome for Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026
Approved Standalone Unaudited Financial Results for the quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Lotus Eye Hospital And Institute Ltd · the 50 most recent filings